XIAP and breast carcinoma: Another recent study has shown that X-linked inhibitor of apoptosis protein (XIAP) functioned as a ubiquitination E3 ligase toward p62 and suppressed p62 expression through ubiquitin-proteasomal degradation and therefore promoted breast cancer progression (Huang et al., 2019).